Pemphigus Foliaceus in Dogs: Welfare Guide
Disease Overview
Pemphigus foliaceus (PF) is the most common autoimmune skin disease in dogs. The immune system produces antibodies against desmoglein-1, a protein holding skin cells together. This causes separation of superficial skin cells, forming vesicles that rupture rapidly to form pustules, erosions, and crusts. Lesions typically start on the face (nose, muzzle, periocular region, ear pinnae) and may generalise. It can be triggered by drugs, UV light, or chronic skin disease, or be idiopathic.
Welfare Impact
PF causes significant discomfort: pruritus, pain, and the cosmetic and tactile distress of widespread crusting. Infection of erosions and secondary bacterial pyoderma worsens pain and discharge. Dogs may paw at their faces, lose appetite, and show reduced activity and social engagement. Footpad involvement causes lameness. Chronic disease without adequate control causes persistent welfare compromise.
Diagnosis
Cytology of intact pustules (acantholytic keratinocytes in a neutrophilic background) is a key diagnostic finding. Skin biopsy with histopathology provides definitive diagnosis. It is important to differentiate PF from other pustular diseases (superficial pyoderma, sub-corneal pustular dermatosis) as treatment differs. ANA (antinuclear antibody) testing is less useful in PF than in systemic lupus erythematosus.
Treatment
Immunosuppressive therapy is required, typically starting with high-dose corticosteroids (prednisolone or methylprednisolone). Steroid-sparing agents (azathioprine in dogs, not cats; ciclosporin; chlorambucil; mycophenolate mofetil) are added to allow reduction of steroid doses. Treatment is often lifelong; the minimum effective dose is sought to balance disease control against side effects (polydipsia/polyuria, weight gain, hepatopathy, immunosuppression).
Long-term Monitoring and Welfare
Regular monitoring of clinical signs, body weight, blood tests (hepatic enzymes, blood glucose, complete blood count) is essential. Owners should be educated about the signs of disease flare and drug side effects. Sun avoidance reduces UV-triggered flares. Most dogs require permanent therapy; sudden withdrawal causes rapid relapse. Quality of life should be regularly assessed, acknowledging the chronic nature of the condition.